| Product NDC: | 62856-681 |
| Proprietary Name: | Zonegran |
| Non Proprietary Name: | zonisamide |
| Active Ingredient(s): | 25 mg/1 & nbsp; zonisamide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, LIQUID FILLED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 62856-681 |
| Labeler Name: | Eisai Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020789 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20000327 |
| Package NDC: | 62856-681-10 |
| Package Description: | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (62856-681-10) |
| NDC Code | 62856-681-10 |
| Proprietary Name | Zonegran |
| Package Description | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (62856-681-10) |
| Product NDC | 62856-681 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | zonisamide |
| Dosage Form Name | CAPSULE, LIQUID FILLED |
| Route Name | ORAL |
| Start Marketing Date | 20000327 |
| Marketing Category Name | NDA |
| Labeler Name | Eisai Inc. |
| Substance Name | ZONISAMIDE |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |